{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:26:17Z","timestamp":1762917977524,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Takeda"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.clml.2019.02.008","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T21:31:33Z","timestamp":1551994293000},"page":"e251-e258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds"],"prefix":"10.1016","volume":"19","author":[{"given":"Brendan A.","family":"Gilmore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger A.","family":"Rodby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cimbaluk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parameswaran","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pritesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Barton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulio","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Sumoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binod","family":"Dhakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parameswaran","family":"Hari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agne","family":"Paner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2019.02.008_bib1","first-page":"74","article-title":"A\u00a0case of bilateral renal arterial thrombosis associated with cryocrystalglobulinaemia","volume":"3","author":"Leung","year":"2010","journal-title":"NDT Plus"},{"key":"10.1016\/j.clml.2019.02.008_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/art.1780390224","article-title":"Multiple myeloma-associated systemic vasculopathy due to crystalglobulin or polyarteritis nodosa","volume":"39","author":"Hasegawa","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clml.2019.02.008_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7326\/0003-4819-110-4-275","article-title":"A\u00a0vasculopathy with deposition of lambda light chain crystals","volume":"110","author":"Stone","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clml.2019.02.008_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/pin.12526","article-title":"Laminar crystal deposition in large vessels in a patient with crystalglobulinemia","volume":"67","author":"Shintani-Domoto","year":"2017","journal-title":"Pathol Int"},{"key":"10.1016\/j.clml.2019.02.008_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.ajkd.2015.11.014","article-title":"Fatal cryocrystalglobulinemia with intravascular and renal tubular crystalline deposits","volume":"67","author":"DeLyria","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clml.2019.02.008_bib6","doi-asserted-by":"crossref","first-page":"e6643","DOI":"10.1097\/MD.0000000000006643","article-title":"Crystalglobulinemia manifesting as chronic arthralgia and acute limb ischemia: a clinical case report","volume":"96","author":"Abe","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clml.2019.02.008_bib7","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.2169\/internalmedicine.53.1775","article-title":"Crystalglobulinemia with fulminant course with cylinder-like bodies on peripheral blood smear","volume":"53","author":"Kawaguchi","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.clml.2019.02.008_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1681\/ASN.2014050509","article-title":"Crystalglobulin-induced nephropathy","volume":"26","author":"Gupta","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.clml.2019.02.008_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.clml.2019.02.008_bib10","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1681\/ASN.2017121319","article-title":"The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases","volume":"29","author":"Sethi","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.clml.2019.02.008_bib11","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2019.02.008_bib12","doi-asserted-by":"crossref","first-page":"e530","DOI":"10.1038\/bcj.2017.14","article-title":"Discrepancies between the percentage of plasma cells in bone marrow aspiration and BM biopsy: impact on the revised IMWG diagnostic criteria of multiple myeloma","volume":"7","author":"Lee","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2019.02.008_bib13","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.02.008_bib14","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","article-title":"Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.02.008_bib15","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","article-title":"International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment","volume":"34","author":"Dimopoulos","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2019.02.008_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2215\/CJN.00560117","article-title":"Dysproteinemias and glomerular disease","volume":"13","author":"Leung","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clml.2019.02.008_bib17","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1200\/JCO.2015.62.4015","article-title":"Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: a Center for International Blood and Marrow Transplant research study","volume":"33","author":"D\u2019Souza","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2019.02.008_bib18","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1182\/blood-2011-11-390930","article-title":"Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis","volume":"119","author":"Mikhael","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.02.008_bib19","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1038\/leu.2014.227","article-title":"Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients","volume":"28","author":"Palladini","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2019.02.008_bib20","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/bmt.2014.115","article-title":"Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up","volume":"49","author":"Parmar","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.02.008_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ajh.23898","article-title":"Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis","volume":"90","author":"Kaufman","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2019.02.008_bib22","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ki.2015.201","article-title":"Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease","volume":"88","author":"Cohen","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.clml.2019.02.008_bib23","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.mayocp.2013.08.002","article-title":"Monoclonal gammopathy-associated proliferative glomerulonephritis","volume":"88","author":"Sethi","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clml.2019.02.008_bib24","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1093\/ndt\/gfr251","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases","volume":"26","author":"Barbour","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clml.2019.02.008_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ckj\/sfx001","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits in two kidney allografts successfully treated with rituximab","volume":"10","author":"Merhi","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.clml.2019.02.008_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-225205","article-title":"Successful management of proliferative glomerulonephritis with monoclonal immune deposits with combined immunosuppressive therapy","volume":"11","author":"Maan","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clml.2019.02.008_bib27","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","article-title":"How I treat monoclonal gammopathy of renal significance (MGRS)","volume":"122","author":"Fermand","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.02.008_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.kint.2018.01.028","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft","volume":"94","author":"Said","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.clml.2019.02.008_bib29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/13506129.2018.1490261","article-title":"Outcomes of patients with AL amyloidosis and low serum free light chain levels at diagnosis","volume":"25","author":"Nguyen","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.clml.2019.02.008_bib30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/leu.2017.286","article-title":"Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains","volume":"32","author":"Sidana","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2019.02.008_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41408-018-0086-3","article-title":"Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis","volume":"8","author":"Kastritis","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2019.02.008_bib32","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.2009010110","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits","volume":"20","author":"Nasr","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.clml.2019.02.008_bib33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.mayocp.2015.01.024","article-title":"Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits","volume":"90","author":"Bhutani","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clml.2019.02.008_bib34","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ajh.24772","article-title":"The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic","volume":"92","author":"Milani","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2019.02.008_bib35","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1515\/cclm-2015-0917","article-title":"Monitoring free light chains in serum using mass spectrometry","volume":"54","author":"Barnidge","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clml.2019.02.008_bib36","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/bmt.2017.28","article-title":"Minimal residual disease (MRD) assessment by flow cytometry after ASCT for AL amyloidosis: are we there yet?","volume":"52","author":"Lee","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.02.008_bib37","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/10428194.2012.671481","article-title":"Type I cryoglobulinemia in multiple myeloma, a rare entity: analysis of clinical and biological characteristics of seven cases and review of the literature","volume":"54","author":"Payet","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.02.008_bib38","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ajh.24745","article-title":"Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia","volume":"92","author":"Sidana","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2019.02.008_bib39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5414\/CP202245","article-title":"Chemotherapy with or without plasmapheresis in acute renal failure due to multiple myeloma: a meta-analysis","volume":"53","author":"Yu","year":"2015","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clml.2019.02.008_bib40","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2017.17924","article-title":"Effect of high-cutoff hemodialysis vs conventional hemodialysis on hemodialysis independence among patients with myeloma cast nephropathy: a randomized clinical trial","volume":"318","author":"Bridoux","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.clml.2019.02.008_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1745-6215-9-55","article-title":"European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trial","volume":"9","author":"Hutchison","year":"2008","journal-title":"Trials"},{"key":"10.1016\/j.clml.2019.02.008_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.ajkd.2003.09.020","article-title":"Long-term outcome of renal transplantation in light-chain deposition disease","volume":"43","author":"Leung","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clml.2019.02.008_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2215\/CJN.08640811","article-title":"Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution","volume":"7","author":"Nasr","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clml.2019.02.008_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbmt.2017.08.031","article-title":"High-dose melphalan and stem cell transplantation in patients on dialysis due to immunoglobulin light-chain amyloidosis and monoclonal immunoglobulin deposition disease","volume":"24","author":"Batalini","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2019.02.008_bib45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/bmt.2008.179","article-title":"High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease","volume":"42","author":"Hassoun","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.02.008_bib46","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/ndt\/gfr067","article-title":"Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation","volume":"26","author":"Herrmann","year":"2011","journal-title":"Nephrol Dial Transplant"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265018317294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265018317294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:32:52Z","timestamp":1761870772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265018317294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S2152265018317294"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2019.02.008","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2019.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}